Cytotoxicity of antitumor agents in a synchronous mammalian cell system.
D000447:Aldehydes / Q000494:pharmacology; D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001375:Azaguanine / Q000494:pharmacology; D001761:Bleomycin / Q000494:pharmacology; D002460:Cell Line; D002478:Cells, Cultured / Q000187:drug effects*; D006224:Cricetinae; D003498:Cyclic P-Oxides / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology; D004987:Ethers / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology; D005347:Fibroblasts; D008168:Lung; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D008938:Mitosis; D009607:Nitrosourea Compounds / Q000494:pharmacology; D010078:Oxazines / Q000494:pharmacology; D008926:Plicamycin / Q000494:pharmacology; D011344:Procarbazine / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium
D000447:Aldehydes; D000477:Alkylating Agents; D000970:Antineoplastic Agents; D003498:Cyclic P-Oxides; D004987:Ethers; D005021:Ethylamines; D009607:Nitrosourea Compounds; D010078:Oxazines; D011687:Purines; D014316:Tritium; D001761:Bleomycin; D011344:Procarbazine; D004317:Doxorubicin; D015122:Mercaptopurine; D008926:Plicamycin; D001375:Azaguanine; D008727:Methotrexate